One of the world's largest makers of medical devices, Medtronic, is considering a takeover of London-based Smith & Nephew, Bloomberg said.
As AstraZeneca's shares slid following its rejection of Pfizer's new bid, the company's chairman said he was "reasonably confident" it was the right decision.
Boston Scientific received a subpoena this week from the Department of Health and Human Services seeking information about its defibrillators.
Johnson & Johnson turned in a solid first quarter Tuesday, topping analysts' profit and revenue estimates and increasing its 2014 earnings forecast by 5 cents a share.
The Gates Foundation has awarded $2 million in grants to several Indian organizations to help improve sanitation by building a high-tech toilet.
Diving into New Year's resolutions to get fit or lose weight may be hazardous to your health.
Inform Fitness uses a 20-minute high intensity workout each week. Founder Adam Zickerman puts "Fast Money" trader John Najarian to work. Intensity is key to results, says Zickerman.
Activist investor Carl Icahn reported a 12.63 stake in medical device maker Hologic, prompting the company to seek protection from a hostile takeover
A detailed look at how a tax on medical devices divided so many over the White House's Affordable Care Act.
JPMorgan Chase, the Bill & Melinda Gates Foundation and others have launched an investment fund focused on late-stage healthcare technology trials.
A research project that gathers more information from hospital monitors than ever before is improving the prognosis of premature infants.
A new Web company is offering to connect inventors of smaller medical devices with people who can give them the cash they need to get off the ground.
Community Health Systems announced it would buy Health Management Associates in a deal valued at approximately $7.6 billion, including about $3.7 billion in debt.
Intuitive Surgical is down about 18 percent today after pre-announcing a huge miss Monday, CNBC's Herb Greenberg brings everyone up to speed; and Jason Mills, analyst at Canaccord Genuity, explains why he downgraded the stock.
Jim Cramer believes this company is about to create immense value with the stroke of a pen.
When architect Michael Graves realized he would spend the rest of his life in a wheelchair, he set out to improve medical design. This week Stryker unveils his wheelchair.
Bristol-Myers Squibb and Merck stocks climbed higher Monday as analysts said billions stood to be made from treatment breakthroughs.
Americans accustomed to immediate access to the newest technology may be shocked to find that is not the case when it comes to devices that treat ailing hearts.
Cramer’s convinced the best way to for this health care company to maximize shareholder value is to break up.
The rise of "superbugs," and pressure from the government and insurers, is driving hospitals to try all sorts of new approaches to stop their spread.